Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implication.

Sadeghi, Nasiredin

Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implication. [electronic resource] - Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 589-99 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1938-2723

10.1177/1076029613479819 doi


Anticoagulants--pharmacology
Benzimidazoles--pharmacology
Blood Coagulation Factors--antagonists & inhibitors
Dabigatran
Electrophoresis, Polyacrylamide Gel
Factor Xa--metabolism
Factor Xa Inhibitors
Humans
Morpholines--pharmacology
Prothrombin--antagonists & inhibitors
Pyrazoles--pharmacology
Pyridones--pharmacology
Rivaroxaban
Thiophenes--pharmacology
Thrombin--biosynthesis
Thromboplastin--metabolism
beta-Alanine--analogs & derivatives